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Ames dwarfouse embryonic pituitary gland transcriptome consisting of ﬁve cDNA libraries
including wild type tissue from E12.5 and E14.5, Prop1df/dfmutant at E14.5, and two cDNA subtractions: E14.5
WT–E14.5 Prop1df/df and E14.5 WT–E12.5 WT. DNA sequence information is assembled into a searchable
database with gene ontology terms representing 12,009 expressed genes. We validated coverage of the
libraries by detecting most known homeobox gene transcription factor cDNAs. A total of 45 homeobox genes
were detected as part of the pituitary transcriptome, representing most expected ones, which validated
library coverage, and many novel ones, underscoring the utility of this resource as a discovery tool. We took a
similar approach for signaling-pathway members with novel pituitary expression and found 157 genes
related to the BMP, FGF, WNT, SHH and NOTCH pathways. These genes are exciting candidates for regulators
of pituitary development and function.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe pituitary gland is a pivotal component of the endocrine system
due to its role in controlling a wide range of fundamental bodily
activities including growth, pubertal development, thyroid gland
function, and the capacity to cope with stress. These critical functions
are regulated by six different hormones secreted by ﬁve specialized
cell types within the anterior pituitary gland, in response to local
stimulatory and inhibitory peptides released by the hypothalamus.
Pituitary development in the mouse begins at embryonic day (E)
9.5 and continues after birth. All of the hormone-secreting cells in the
anterior lobe derive from a single primordial tissue, Rathke's pouch,
which forms from the oral ectoderm adjacent to the base of the
developing brain. Formation of Rathke's pouch occurs in contact with
a specialized region of the neuroectoderm, the infundibulum, which
will later form the posterior lobe of the pituitary gland.
The molecular mechanisms underlying pituitary organ growth
and cell differentiation are complex. Signaling molecules including
FGF, BMP, NOTCH, WNT and SHH family members have roles in
establishing regional identity within Rathke's pouch and contribute toInstitute of Life Sciences, Penn
ll rights reserved.its growth [1–5]. The overall effect of these signaling molecules is to
induce the regional expression of numerous critical transcription
factors, which control the differentiation of the hormone secreting
cells between E13.5 and birth.
Failed or incomplete differentiation of anterior pituitary cells
during embryonic development can result in the genetically hetero-
geneous disorder, Multiple Pituitary Hormone Deﬁciency (MPHD).
Molecular genetic analysis of spontaneous and genetically engineered
mouse mutants with pituitary defects has revealed a functional role
for many homeobox transcription factors in the etiology of MPHD in
mouse and man. These include Prop1, Pou1f1, Hesx1, Lhx3, Lhx4, Otx2,
Pitx1, and Pitx2 [reviewed by [6–8]. Lesions in these genes only
account for approximately half of the known genetic MPHD, sug-
gesting that many of the key factors involved in the process of
pituitary cell proliferation and differentiation remain unknown.
Mutations in PROP1 are the most common known genetic cause of
MPHD in humans [9]. Patients with PROP1 mutations commonly
exhibit deﬁciencies in Growth Hormone (GH), Prolactin (PRL),
Thyroid Stimulating Hormone (TSH) and gonadotropins, with evol-
ving adrenocorticotropin deﬁciency (ACTH). Similarly, the sponta-
neous Ames dwarf mouse model (Prop1df/df), that harbors a
homeodomain mutation in Prop1 displays a phenotype that includes
hypoplasia of the anterior pituitary accompanied by nearly complete
loss of the hormone-secreting cell types that produce GH (somato-
tropes), PRL (lactotropes), and TSH (thyrotropes) [10–13].
Table 1
Number and distribution of cDNA clones in the embryonic pituitary encyclopedia
a E14.5 WT-E14.5 Prop1.df/df
b E14.5 WT-E12.5 WT.
c Example interpretation: clones sequenced from the E12.5 WT library matched 4192
different UniGene entries,1246were unique to this library, 3029were found in all libraries.
d Library-speciﬁc transcripts are on the diagonal, shaded in gray.
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viability of Prop1 deﬁcient mice than any functional difference
between the Prop1df and Prop1null alleles, suggesting that genetic
modiﬁers may inﬂuence the clinical features of some MPHD patients
[13].
Prop1 expression is ﬁrst detectable in Rathke's pouch at E10–10.5.
It reaches a peak at E12.5 after which time expression declines rapidly
[14]. A time of intense cell proliferation occurs in the developing
pituitary from E12.5–E14.5, which precedes the appearance of the
differentiated pituitary cell types. The effects of mutations in Prop1
and other critical transcription factors including Pitx2, Lhx3 and Hesx1
are evident at this time [15–17]. This suggests that potential Prop1
targets and other important as yet unknown transcription factors may
be expressed around E12.5 and/or E14.5.
At E12.5 the anterior pituitary is composed primarily of prolife-
rating, undifferentiated cells. There is a very small group of non-
proliferating cells that have begun to differentiate and express Foxl2
and the alpha subunit of the gonadotropins and thyrotropin, Cga [18].
At this developmental time Prop1df/df and WT pituitaries are
indistinguishable in size and morphology [13,19]. By E14.5 there are
more cells in the anterior lobe of normal mice, and they appear loosely
packed and glandular. In contrast, the pituitary glands of Prop1df/df
mutants are highly dysmorphic at E14.5 because cells apparently fail
to migrate away from the dorsal aspect of the gland and colonize the
anterior lobe. They exit the cell cycle but fail to differentiate [13,19,20].
We exploited the Prop1df/df model to gain insights into the
embryonic pituitary transcriptome. We used cDNA subtractive hybri-
dization between Prop1df/df and wild type pituitary gland primordia at
E14.5 to identify differentially expressed genes in mutant and normal
embryonic pituitary [21]. We took a differential display approach to
deﬁne an expression proﬁle for the developing anterior pituitary at
E12.5 and E14.5 by comparing Rathke's pouch tissue from wild type
samples taken at these times [22]. Collectively, these studies repres-
ented the ﬁrst expression proﬁles of the developing pituitary gland
and also paved the way for demonstrating the role of the Wnt
signaling pathway in regulating pituitary growth. More speciﬁcally,
these studies identiﬁed Wnt5a, Aes and Tcf7l2 in the developing
pituitary. We have now demonstrated functional roles for each of
these genes in pituitary development through the analysis of corres-
ponding mutant mouse models [2,23–25].
Numerous gene expression proﬁling studies have been carried out
using adult pituitary tissue and cell lines, but only a few studies have
addressed developmental changes in pituitary gene expression aside
from those with the Prop1df/df model [26,27]. Alterations due to aging
and caloric restriction have been investigated [28] and some studies
with cell lines have implicated transcription factors as potential regu-
lators of development and cell proliferation [29,30]. The expression
studies with adult pituitary tissue and cell lines identiﬁed collections
of potentially pituitary-speciﬁc genes [31,32], candidates for tumor
biomarkers and mechanistic involvement in pituitary adenoma
formation [reviewed in [33], and pathways induced by hormonal or
growth factor treatment [34–37].
Our studies with the Prop1df/df model have been proven valuable
for novel gene discovery and dissection of the genetic differences
between the wild type and mutant pituitary; although, a major
limitation for functional studies has been the lack of full-length cDNAs
available. In addition, previous approaches have not addressed the
depth and complexity of the developing pituitary transcriptome
speciﬁcally. To overcome these limitations we generated a full-length
cDNA encyclopedia of themouse embryonic pituitary gland comprised
of 5 transcriptome volumes including three samples and genotypes:
E12.5 wild type pituitary (E12.5 WT), E14.5 wild type pituitary (E14.5
WT) and E14.5 Prop1df/df pituitary [38], and two subtracted libraries:
E14.5 WT–E14.5 Prop1df/df, WT E14.5–WT E12.5. We selected these
times and genotypes because we expected E14.5 Prop1df/df mutants to
continue to express genes that are normally expressed at E12.5 andwane in expression by E14.5 such as Hesx1 [12]. We also expected to
ﬁnd genes normally activated by Prop1, and expressed at E14.5 in WT
mice, but absent in the E14.5 Prop1df/dfmutant, such as Pou1f1 [10] and
Notch2 [3]. Using the Cap-trapper method to enrich for full-length
clones [39–43], followed by aggressive subtraction and normalization,
we produced full-length cDNA libraries and generated DNA sequence
from 56,716 cDNA clones. The comparison and global analysis of the
transcripts contained within each library reveals expression of 12,009
unique genes thatwe have integrated into a comprehensive searchable
database. We demonstrate the integrity, validity, utility and novelty of
the database by identifying 45 homeobox genes expressed in the
developing anterior pituitary gland and 157 genes related to the BMP,
FGF,WNT, NOTCH or SHH signaling pathways, many of whichwere not
previously known to be part of the developing pituitary transcriptome.
Results
The embryonic pituitary encyclopedia is a rich source for gene discovery
Wesought to investigate thedepth and complexity of the developing
pituitary transcriptome, while maximizing novel gene discovery and
developing full-length clones that could be exploited for functional
studies of the developing pituitary gland. ‘Phase I’ involved end
sequencing of clones from three embryonic pituitary libraries (E12.5
WT, E14.5 WT and E14.5 Prop1df/df) until less than 10% of the new
sequences produced novel information [38]. 20,270 sequences were
obtained from the 5′ end, 51,379 were sequenced from the 3′ end, and
14,933 were sequenced from both ends. Here, we present the
identiﬁcation and characterization of the cDNAs from these three
libraries.Wealso present twoadditional libraries thatweregeneratedby
a subtractive hybridization analysis between E14.5 WT and E14.5
Prop1df/df (Sub1) and between E14.5 WT and E12.5 WT (Sub2).
We conducted single pass end-sequencing of 56,716 unique cDNA
clones from theseﬁve libraries. The sequenceswere eachqueried using
BLAST analysis against the UniGene unique subset of the NCBI Mus
musculus database (Build #159, www.ncbi.nlm.nih.gov/UniGene/).
The same sequences were also subjected to BLAST analysis against the
mouse-speciﬁc Reference Sequence (RefSeq) (Release #20, www.ncbi.
nlm.nih.gov/RefSeq/). Clones were identiﬁed based on the ﬁrst BLAST
identity recorded with an expect value of 1x10e-5 or lower. This
analysis identiﬁed 51,352 clones present in the encyclopedia. 5364
clones were not identiﬁed by BLAST analysis. While some of these
clones have poor sequence quality through the polyA stretch at the 3′
end that interferes with BLAST analysis, we anticipate that some of
these cloneswill be identiﬁedwhen compared tomore recent UniGene
and Refseq builds. Further analysis to determine the number of unique
genes represented revealed 12,009 different cDNA clones distributed
between the ﬁve libraries.
Fig. 1. Distribution of clone representation per unique transcript for the E14.5 WT
library. 4339 unique UniGene entries are contained in the E14.5 WT library (Table 1).
Over half of these (2644) are represented by a single cDNA clone (shown in the ﬁrst
column). A continually decreasing trend is observed, such that as the number of
replicates or cDNA clones increases, the number of genes represented by these clones
decreases. Number of Replicates (X axis) refers to the number of clones representing
each unique UniGene entry. Frequency (Y axis) refers to the number of unique UniGene
entries represented.
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library, the number of library-speciﬁc genes represented, and the
distribution of cDNA clones relative to each of the ﬁve libraries in
different pair-wise combinations. In terms of library-speciﬁc tran-
scripts, 1246 genes in the encyclopedia were unique to E12.5 WT, 642
to E14.5 WT, 1256 to E14.5 Prop1df/df, 629 to the subtraction of E14.5
Prop1df/df from E14.5 WT, and 1264 from the subtraction of E12.5 WT
from E14.5 WT. 631 genes were expressed universally in all libraries.
The majority of genes are represented by a small number of clones
The underlying principle of our approach was to develop a tool for
novel gene discovery that addressed the depth and complexity of the
embryonic pituitary transcriptome. Our sequencing effort was
designed to maximize gene identiﬁcation and enrich for those genes
that were rare rather than abundant. The extremely high ranking of
these libraries with regard to novelty in a pool consisting of 246
libraries generated from 71 different tissues is evidence of success
[38]. The E14.5 Prop1df/df library ranked 1/246, where 24% of the
unique clones sequenced in this library were found to be novel, and
the libraries from E14.5 WT and E12.5 WT also ranked highly, 8/246
and 16/246, respectively. Another measure of success is to ascertain
the distribution of clone representation per unique gene with the
expectation that the majority will have few replicates. This trend was
observed in all ﬁve libraries. Fig. 1 shows the results for the E14.5 WT
library following analysis. The same trend was observed in all of the
other libraries (data not shown).
All three non-subtracted cDNA libraries contribute unique genetic
information
To gain greater insight into the unique cDNA distribution between
the three non-subtracted libraries, we compared the relative dis-tribution of 12,894 cDNA clones between the E12.5 WT, E14.5 WT
and E14.5 Prop1df/df libraries (Fig. 2a). Overall, there is similar
overlap between transcripts detected in these three libraries, where
any two of the three libraries considered share at least 11–12% clone
representation. Each of the three libraries contains a signiﬁcant pro-
portion of apparently library-speciﬁc genes (14%), suggesting that
each library contributes an important collection of unique genes to
the encyclopedia that may be dependent on developmental stage and
genotype.
The two subtracted libraries each add a dimension of genetic novelty to
the encyclopedia
We compared the relative distribution of 13,035 cDNA clones
between the E14.5 WT, E14.5 Prop1df/df and Sub1 libraries (Fig. 2b).
The Sub1 library (E14.5 WT minus E14.5 Prop1df/df) should theoreti-
cally represent those genes expressed at E14.5 in normal pituitaries
but not in Prop1df/df mutants. This trend is observed, suggesting that
the subtraction was effective. Gene representation in the E14.5 WT
and Sub1 libraries overlaps by 16% compared to a 13% overlap between
E14.5 Prop1df/df and Sub1. The percentage of genes expressed in both
E14.5 WT and E14.5 Prop1df/df is also 10%. This implies that the Sub1
and E14.5 Prop1df/df libraries are as different as the E14.5WTand E14.5
Prop1df/df libraries in terms of the expressed genes being detected or
sampled. In addition to those genes that were detected in both E14.5
WT and Sub1, there are also genes detected in only one library.
Uniquely represented genes constitute 10–14% of the total expressed
genes, which equates to 1612 genes in the case of the Sub1 library,
demonstrating that it adds a dimension of genetic novelty to the
encyclopedia.
We evaluated the E12.5 WT, E14.5 WT and Sub2 libraries, com-
paring 14,509 clones (Fig. 2c). The Sub2 and E14.5 WT libraries
should share expression of a larger subset of genes compared to
E14.5 WT and E12.5 WT, and this trend was observed. E14.5 WT and
Sub2 common transcripts overlap by 17%, compared to an overlap of
10% between E14.5 WT and E12.5 WT. This overlap is equivalent to
that observed between Sub2 and E12.5 WT (13%) suggesting that
this subtraction was also effective. The Sub2 library adds new
information to the encyclopedia as 2283 (16%) unique cDNA clones
present in the Sub2 library were not sampled in the E14.5 WT or
E12.5 WT libraries.
Gene Ontology (GO) terminology reveals novel library-speciﬁc biological
processes
We wanted to determine the unique biological processes
represented in each library as a means for identifying the genes
that contribute to the morphological and functional differences in
pituitary development [13,19]. Using Gene Ontology (GO) terms we
probed the ﬁve sets of genes uniquely sampled from each library for
enriched processes and also analyzed the set of genes that were
detected universally. Twelve GO terms were signiﬁcantly enriched
(unadjusted p-valueb0.01) in the universally expressed transcript
set (Table 2). Enriched terms include ‘translation’, ‘RNA splicing’,
‘protein folding’ and ‘protein transport’, fundamental biological
processes that are active in all tissues, irrespective of developmental
stage or genotype.
The E14.5 WT library contains three signiﬁcantly over-represented
GO terms; ‘spermidine metabolic process’, ‘hydrogen peroxide
catabolic process’, and ‘defense response to bacterium’ (Table 2).
While these were unexpected, it is not difﬁcult to envision how genes
in these categories could be engaged in other known processes that
occur predominantly at this time. For example, spermidine markedly
increases DNA binding activity of certain transcription factors in the
pituitary gland [44]. It may, therefore, play an important role in the
changing transcription characteristic of the developing pituitary at
Fig. 2. Venn diagrams illustrate the relationships between the ﬁve libraries in the encyclopedia. (A) Comparison of a total of 12,894 genes from the E12.5 WT, E14.5 WT and E14.5
Prop1df/df. (B) Comparison of a total of 13,035 genes from the E14.5WT, E14.5 Prop1df/df and Sub1 libraries. (C) Comparison of a total of 14,509 genes from the E12.5WT, E14.5WTand
Sub2 libraries.
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ﬁcantly enriched in the Prop1df/df library (Table 2) and is represented
by more genes, compared to the E14.5 library (data not shown).
The E14.5 Prop1df/df library sampling was enriched for six GO terms
(Table 2), ﬁve of which are not over-represented in any of the other
library samples, providing clues regarding the types of processes
occurring in the Prop1df/df pituitary that could differ from the normal
state. For example, ‘Response to oxygen radical’ was enriched, a
process that is involved in apoptosis, which is elevated in Prop1df/df
[19,45]. Two signiﬁcantly over-represented GO terms emerged from
the E12.5 WT library sample (Table 2). ‘Positive regulation of calcium
signaling’ precedes the catabolism of spermidine in the pituitary,
which was represented at E14.5, and the role for calcium signaling is
well documented [46,47]. The Sub1 and Sub2 library samples
collectively contain four over-represented GO terms, which do not
appear in any of the other samples (Table 2). ‘Exocytosis’ and
‘response to pH’ may provide a platform on which to launch future
functional studies for some of the genes represented.
Validation of the embryonic pituitary encyclopedia
To validate the ﬁve libraries that comprise the embryonic pituitary
encyclopedia we queried the database for the presence of several‘knowns’, consisting of some homeobox genes with well-character-
ized roles in the developing pituitary gland and related gene family
members. Searches for gene name, UniGene ID, and DNA or peptide
sequences identiﬁed nine homeobox genes in the database (Table 3).
Pou1f1, a target of Prop1 [14] was detected in the E14.5WT library, and
not in the E14.5 Prop1df/df library, as expected. Lhx3, Pitx1 and Pitx2,
and two members of the Six gene family, were identiﬁed in several
libraries [6,48–51]. Other expected genes detected included Otx2,
Prop1, and Pax6 [6,7,52]. Three of the expected homeobox genes, Lhx4,
Hesx1, and Pou3f4, were not detected in the database following in
silico searching. Absence from the database can be an artifact of the
sampling strategy for sequencing. For example, Hesx1was detected by
PCR at the expected developmental stages, suggesting that deeper
sequencingwould have revealed the presence of these genes (data not
shown).
To conﬁrm the identity and integrity of the clones identiﬁed
computationally from end sequence, at least one clone representing
each homeobox gene identiﬁed in Table 3 was sequenced from both
ends and examined to determine whether the libraries were enriched
for full-length clones. In most cases the clones were full-length
compared to the NCBI Mus musculus UniGene database (Build #159)
validating the Cap-trapper technique for producing full-length clones.
This validation strategy revealed that the high throughput ﬁrst pass
Table 2
Enriched gene ontology (GO) terms
GO terma Description p valueb
Universally expressed gene set
GO:0006412 Translation 0.0000012
GO:0006457 Protein folding 0.0000027
GO:0015671 Oxygen transport 0.000043
GO:0008380 RNA splicing 0.00013
GO:0006397 mRNA processing 0.00029
GO:0009408 Response to heat 0.00143
GO:0006986 Response to unfolded protein 0.00235
GO:0015031 Protein transport 0.00242
GO:0046907 Intracellular transport 0.00419
GO:0006334 Nucleosome assembly 0.00629
GO:0000398 Nuclear mRNA splicing, via spliceosome 0.00739
GO:0030198 Extracellular matrix organization and biogenesis 0.00907
E12.5 WT
GO:0019068 Virus assembly 0.0007
GO:0050850 Positive regulation of calcium-mediated signaling 0.0077
E14.5 WT
GO:0008216 Spermidine metabolic process 0.002
GO:0042744 Hydrogen peroxide catabolic process 0.002
GO:0042742 Defense response to bacterium 0.005
E14.5 Prop1df/df
GO:0042742 Defense response to bacterium 0.0003
GO:0006952 Defense response 0.0012
GO:0048015 Phosphoinositide-mediated signaling 0.0062
GO:0051046 Regulation of secretion 0.0062
GO:0000305 Response to oxygen radical 0.0083
GO:0006111 Regulation of gluconeogenesis 0.0083
Sub1 (E14.5 WT–E14.5 Prop1df/df)
GO:0030174 Regulation of DNA replication initiation 0.002
GO:0007264 Small GTPase mediated signal transduction 0.005
Sub2 (E14.5 WT–E12.5 WT)
GO:0009268 Response to pH 0.002
GO:0006887 Exocytosis 0.004
a www.geneontology.org.
b GO terms with an unadjusted p-valueb0.01 are listed.
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accurately. The misidentiﬁed clones tended to be ones with poor
expect values from the initial BLAST analysis.
Identiﬁcation of additional homeobox genes in the embryonic pituitary
encyclopedia
Given the critical roles of numerous homeobox genes in the dev-
eloping pituitary gland, we used the database as a tool for discovering
additional homeobox genes expressed in the pituitary gland. TheTable 3
Libraries contain homeobox genes implicated in pituitary development
Gene
symbol
Gene name Unigene IDa
Lhx3 LIM homeobox protein 3 Mm.386765
Otx2 Orthodenticle homolog 2 Mm.134516
Pax6 Paired box gene 6 Mm.3608
Pitx1 Paired-like homeodomain transcription factor 1 Mm.135195
Pitx2 Paired-like homeodomain transcription factor 2 Mm.246804
Pou1f1 POU domain, class 1, transcription factor 1 Mm.457971
Prop1 Paired like homeodomain factor 1 Mm.1386
Six3 Sine oculis-related homeobox 3 homolog Mm.370208
Six6 Sine oculis-related homeobox 6 homolog Mm.57138
a NCBI UniGene accession number.
b Number of cDNA clones identiﬁed in each library corresponding to indicated gene. Blan
c E14.5 WT–E14.5 Prop1df/df.
d E14.5 WT–E12.5 WT.database is searchable using a combination of text searching with
the terms ‘homeo’, ‘homeobox’ and ‘homeodomain’ or querying the
database using the 60 amino acid homeodomain consensus se-
quence [53]. The most comprehensive method was to search using
gene names that are included in a list of homeodomain containing
proteins at Prosite (http://ca.expasy.org/prosite/). We recovered
numerous additional homeobox genes expressed in the encyclopedia
(Table 4).
Differential expression analysis conﬁrms transcription of novel
homeobox genes
We analyzed 23 of these genes with respect to expression in the
developing pituitary gland at E12.5, E14.5, and E18.5 using a combina-
tion of in situ hybridization analysis, RT-PCR, and quantitative PCR. Fig. 3
shows a subset of the in situ hybridization results. Dlx3 and Rax
expression was conﬁrmed at E14.5 (Fig. 3a and c) and Dlx1 and Zhx1 at
E14.5 (Fig. 3b and d). For PCR analyses cDNAwas generated from E12.5,
E14.5, and E18.5 WT, and E14.5 Prop1df/df pituitary primordia. The
quality of these cDNAs was conﬁrmed using a series of primers speciﬁc
for Prop1, Pou1f1, Hesx1, and Hprt1 (Fig. 4, data not shown). Using
standard RT-PCR expression of 12 genes was conﬁrmed during pituitary
gland development. Meis1, Adnp, Prrx2, Lhx2, Zfhx3, Pknox2, Pbx2, and
Meis2 were expressed at similar levels at all time points analyzed in
wild type and in Prop1df/df Rathke's pouch cDNA. Meox2, Emx2, Otx2,
and Zeb2 appeared to exhibit developmentally regulated expression,
with the peak expression ofMeox2 at E12.5, Emx2 at E14.5, and Zeb2 at
E18.5 (Fig. 4a). In addition, expression of Meox2 and Otx2 appeared
elevated in Prop1df/df mutant Rathke's pouch compared to wild type
controls. Quantitative Real Time PCR was used to conﬁrm the results
suggested by standard RT-PCR (Fig. 4b). cDNA was generated from
additional E12.5, E14.5, E18.5 WT, and E14.5 Prop1df/df pituitary
primordia and the quality conﬁrmed using primer sets for Prop1 and
Pou1f1. All samples were done in triplicate and normalized to Hprt1.
The fold activation was determined by comparison to E14.5 WT, which
was set to 1. Both Meox2 and Otx2 peak in expression at E12.5 and are
elevated 7.9 and 6 fold, respectively, relative to E14.5 WT. The peak
expression of Emx2 is between E12.5 and E14.5, while Zeb2 peaks later in
development at E18.5.Meox2 and Otx2 are slightly elevated in the E14.5
Prop1df/df mutants relative to E14.5 WT by 1.59 fold and 2.06 fold,
respectively. Zeb2, Adnp, and Meis1 are decreased in the Prop1df/df
mutants relative to E14.5 WT by 2.09, 2.15, and 2.39 fold, respectively.
Prrx2 does not exhibit developmental regulation or differences between
wild type and Prop1df/df. Taken together these results suggest that
Meox2, Otx2, Zeb2, Adnp, and Meis1 could merit further evaluation as
downstream targets of Prop1.
The identiﬁcation of individual homeobox genes in the speciﬁc








5 3 2 5
1
1
1 1 2 3
2 1 2 5
3
2 2 4
1 1 1 3
4 8 5 1 2
k indicates none.
Table 4
Identiﬁcation of additional homeobox genes in the embryonic pituitary encyclopedia
Gene
symbol
Gene name Number of clones identiﬁed a pituitary cDNA source Homeobox
classbE12.5 WT E14.5 WT E14.5 Prop1df/df Sub1 Sub2
Adnp Activity-dependent neuroprotective protein 1 3 3 POU-like
Dlx1 Distal-less homeobox 1 1 3 Dll
Dlx3 Distal-less homeobox 3 1 Dll
Emx2 Empty spiracles homolog 2 3 1 EMS
Hlx H2.0-like homeo box 1 HLX
Homez Homeodomain leucine zipper-encoding 2 1 ZF
Isl1 Islet 1 transcription factor 2 1 LIM
Lass2 LAG1 homolog, ceramide synthase 2 3 2
Lass3 LAG1 homolog, ceramide synthase 3 1
Lass4 LAG1 homolog, ceramide synthase 4 3 3
Lass5 LAG1 homolog, ceramide synthase 5 1 1 2
Lass6 LAG1 homolog, ceramide synthase 6 3 2
Lhx2 LIM homeobox protein 2 [69] 1 LIM
Meis1 Myeloid ecotropic viral integration site 1 1 TALE
Meis2 Myeloid ecotropic viral integration site-related gene 1 [66,71] 2 1 TALE
Meox2 Mesenchyme homeobox 2 1 TALE
Msx1 Homeobox, msh-like 1 [67,86] 1 1 1 MSH
Nkx2-4 NK2 transcription factor related, locus 4 2 NK
Nkx3-1 NK-3 transcription factor, locus 1 3 NK
Pax1 Paired box gene 1 2 2 PRD
Pbx2 Pre B-cell leukemia transcription factor 2 1 3 TALE
Pknox1 Pbx/knotted 1 homeobox 1 [64] 1 TALE
Pknox2 Pbx/knotted 1 homeobox 2 1 TALE
Pou4f1 POU domain class 4, transcription factor 1 [37] 1 1 POU
Pou6f1 POU domain class 4 transcription factor 1 [70] 1 POU
Prrx2 Paired related homeobox 2 1 PRD
Prrxl1 Paired related homeobox protein-like 1 2 PRD
Rax Retina and anterior neural fold homeobox [63] 2 2 1 PRD
Satb1 Special AT-rich sequence binding protein 1 2 1 3 CUT
Six1 Sine oculis-related homeobox 1 homolog 5 2 4 10 6 SIX
Six4 Sine oculis-related homeobox 4 homolog 1 3 2 SIX
Tgif1 TGFB-induced factor homeobox 1 1 1 TALE
Tgif2 TGFB-induced factor homeobox 2 2 TALE
Zeb2 Zinc ﬁnger E-box binding homeobox 2 [60] 1 ZF
Zfhx3 Zinc ﬁnger homeobox 3 1 2 ZF
Zhx1 Zinc ﬁngers and homeoboxes protein 1 2 ZF
a Number of cDNA clones identiﬁed in each library corresponding to indicated gene.
b Homeobox class is indicated where known. None known for Lass family.
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E12.5 library; however, our RT-PCR data show that it is expressed at
E12.5, E14.5, and E14.5 Prop1df/df embryos. Therefore, it is mislead-
ing to assume that the identiﬁcation of a gene in a speciﬁc library or
even a subtracted library provides accurate differential expression
information.
Database analysis implicates additional signaling molecules in pituitary
development
Fundamental to the current understanding of the genetic mechan-
isms driving pituitary development has been the identiﬁcation of
numerous signaling pathways that exert their effects on the pituitary
primordia. Previous studies have demonstrated the importance of
individual members of the BMP, FGF, NOTCH, SHH and WNT signaling
pathways in directing normal pituitary development [1–3,5,23–
25,54,55]. A continuing challenge in the ﬁeld is to identify additional
members of these pathways and to determine how these various
signaling pathways interact with each other during pituitary organo-
genesis to promote development of the organ.
We used Genomatix software (www.genomatix.de/) to build
functional genetic networks for signaling pathways known to affect
pituitary development and queried the database for the expression of
these genes. For example, in the case of the BMP pathway, a group of
78 Bmp-related genes emerged, and we identiﬁed 20 of them in the
encyclopedia. This analysis was conducted for additional pathways,revealing a total of 61 genes expressed in the developing pituitary
gland related to the BMP (N=20), FGF (N=13), NOTCH (N=2), SHH
(N=1) or WNT (N=25) signaling pathways. A subset corresponding
to the FGF pathway is shown in Table 5, and the complete list is
available in Supplementary Table 1. 17 additional genes were
identiﬁed that are involved in functional crosstalk between two or
more signaling pathways (Table 5 and Supplementary Table 1).
As an alternative strategy we searched the library for GO terms
related to signaling and for speciﬁc gene names for genes known to be
involved in the BMP, FGF, NOTCH, SHH, and WNT pathways. This
search identiﬁed an additional 72 genes (Supplement Table 1). This
list has not been veriﬁed by end sequencing yet.
Spatial expression of three Bmp-related genes in the developing pituitary
We searched the set of 61 signaling genes described above for
those with previously demonstrated roles in the developing pituitary.
Twelve “known” genes are in the set including Aes and Tle4 [23],
Bmpr1a and Bmpr1b [56], Chrd [55], Fgf10 [1] Nkx2-1 [4], Hey1 and
Notch2 [3], Wnt5a [2,25,55], Axin2 [2,57] and Fzd5 [21] (Supplemen-
tary Table 1). Previously we presented the expression pattern for the
BMP signaling related genes Nbl1 and Fstl1, found in our develop-
mental library, at E12.5 and E14.5, and for Id3 at E10.5 [54]. We
expanded the analysis of Id3 and examined the expression of Id2 and
Tgfbi (Fig. 5). Id2 expression was detected in the dorsal aspect of
Rathke's pouch at E12.5 (Fig. 5a). Expression persists at E14.5 in the
Fig. 3. In situ hybridization of four homeobox genes with novel expression in the
developing pituitary gland. In situ hybridization analysis of Dlx3 at E14.5 (A) Dlx1 at
E12.5 (B), Rax at E14.5 (C) and Zhx1 at E12.5 (D) in the developing pituitary indicates
robust expression. (A) At E14.5 Dlx3 is expressed strongly in the intermediate lobe (as
well as in the posterior pituitary (PP) and throughout the expanding Rathke's pouch
(RP). (B) At E12.5 Dlx1 is expressed throughout Rathke's pouch and the intermediate
lobe. Expression appears concentrated in the dorsal aspect of the pouch, as shown by
the white arrow. Dlx1 expression is also present in the ventral diencephalon (VD). Rax
(C) and Zhx1 (D) are expressed throughout the developing Rathke's pouch (RP). Sense
controls corresponding to each gene are shown in the top left hand corner of each
panel.
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cells closest to the lumen of the pouch. Id2 does not appear to be
expressed in the proliferating cells of the expanding Rathke's pouch.
By E16.5 Id2 expression is barely detectable in the pituitary (data not
shown). Id3 expression was detected in Rathke's pouch at E12.5,
enriched in the dorsal part of the pouch and in the intermediate lobe
(Fig. 5c). Similar to Id2, Id3 expression does not appear in the proli-
ferating cells of the expanding Rathke's pouch. Expression of Id3
continues at E14.5 (Fig. 5d) in a similar pattern, restricted to the dorsal
pouch and intermediate lobe and is barely detectable by E16.5 (data
not shown). Tgfbi showed a striking expression pattern. While there
are no transcripts in Rathke's pouch itself, the gene is expressed in the
mesenchymal tissue immediately surrounding the pouch at E12.5 (Fig.
5e). At E14.5, this expression continues more strongly and is also
detectable surrounding the posterior pituitary (Fig. 5f). Like Id2 and
Id3, Tgfbi expressionwanes by E16.5. These studies conﬁrm expression
of these genes in the pituitary and support the encyclopedia as reﬂec-
tion of pituitary gene expression.
Interplay of signaling pathways in the developing pituitary
We surveyed the signaling genes represented in the encyclopedia
using Genomatix software to identify those genes that displayed a
functional overlap between two or more of the ﬁve pathways deﬁned
in Supplementary Table 1. This analysis revealed the presence of anadditional 16 genes in our encyclopedia that are involved in functional
cross talk during organ development, including pituitary (Supple-
mentary Table 1). A subset of these (4/16) is shown in Table 5.
4/16 genes of the pathway interaction genes identiﬁed belong to
the helix–loop–helix transcription factor family (Table 5). These
include Ascl1 and Id1. The zebraﬁsh Ascl1 orthologue (Ascl1a) is a
critical gene for pituitary cell differentiation and cell survival [58].
Zebraﬁsh Fgf3 mutants fail to express Ascl1a, suggesting that Ascl1a
acts downstream of Fgf. Zebraﬁsh Fgf3 is orthologous to mammalian
Fgf10, known for its function in mammalian pituitary development,
implying a conserved mechanism for FGF signaling and Ascl1
expression [1]. Additionally, Id1 mediated expression of Bmp2 leads
to reduced Ascl1 expression [59]. Ascl1, Id1, Id2, Id3, and Id4 are all
implicated as differentially expressed in pituitary tumors [28,60–62].
Together these studies suggest a functional link between FGF and BMP
signaling and identify the Id gene family and Ascl1 as interesting
candidates in mediating cell differentiation in the developing pitui-
tary. This example demonstrates the utility of the embryonic pituitary
encyclopedia in providing a foundation for furthering our under-
standing of signaling in the developing pituitary.
Discussion
In previous studies we described a partial expression proﬁle of the
developing pituitary gland and paved the way for understanding the
role ofWNTsignaling in pituitary development using a combination of
differential display PCR [22] and subtractive hybridization [21]. The
datasets generated in these studies were fairly small (b400 genes in
each), but the gene discovery was signiﬁcant, providing proof of
principle that generation of a more comprehensive pituitary tran-
scriptome proﬁle would likely enable signiﬁcant gene discovery and
provide insight into the transcription factors and signaling molecules
expressed in the developing pituitary.
In this study we generated a full-length cDNA encyclopedia of
the developing pituitary at wild type E12.5 and E14.5 and in the
Prop1df/df pituitary at E14.5 using an approach designed to enrich for
full-length clones,maximize gene discovery, and permit high through-
put gene recovery [38,40–43]. Using sequence data from these libraries
we built a comprehensive database throughwhich to access transcript
information. It is searchable by Gene Ontology (GO) terminology;
direct sequence query, including nucleic and amino acid sequence;
gene name or text-string options; motifs for transcription factor
binding; and UniGene ID and database-speciﬁc clone number. This
encyclopedia contains 12,009 unique transcripts, represented by 56,716
cDNA clones, and accounts for over half of the known genes in the
mouse genome (22,723) (http://www.ensembl.org/Mus_musculus/
index.html). Thus, the developing pituitary transcriptome has depth
and complexity, and our study provides clones ideal for use in func-
tional studies such as cell culture transfection and the generation of
transgenic mice.
Each of the libraries contained within the encyclopedia includes a
set of library-speciﬁc cDNA clones representing between 629 (Sub1)
and 1264 (Sub2) unique transcripts. Exclusivity in any one library is
not a true readout of the pituitary transcriptome, but rather, a
reﬂection of the sequencing approach taken. Novelty and enrichment
for rare transcripts were favored in place of the complete sequencing
of any one library. Despite this limitation, the GO terminology analysis
suggests that certain biological processes are signiﬁcantly enriched in
a library-speciﬁc manner. The genes represented by these processes
could provide the basis for future novel mechanistic studies of
embryonic pituitary development.
We identiﬁed a total of 45 homeobox genes that are expressed in
the developing pituitarygland, expanding signiﬁcantlyon the subset of
homeobox genes with well-characterized roles. Transcripts for seven
of these newer genes have been detected in pituitary cell lines (Lhx2,
Meis2, Pknox1, Pou6f1), pituitary adenomas (Pou4f1, Zeb2), or other
Fig. 4. Expression of homeobox genes in the developing wild type and Prop1df/df pituitary. (A) Pituitary expression of a set of homeobox genes identiﬁed in the embryonic pituitary
encyclopedia was validated by RT-PCR using cDNA generated from pituitary primordia at E12.5, E14.5, E18.5, and Prop1df/df E14.5. The homeobox genesMeox2, Emx2, Otx2, and Zeb2
show differential expression between E12.5–E18.5 and in the Prop1df/df E14.5 pituitary, while Meis1, Adnp, and Prrx2 showed similar expression in all samples. Hprt1 is a control for
RNA and cDNA quality. Differential expression was quantitated using Real Time PCR (B). The quality of the cDNA samples was conﬁrmed by demonstrating the expected pattern of
Prop1 and Pit1 expression.Meox2, Emx2, Otx2, Prrx2,Meis1 and Adnp expression levels were validated using pituitary cDNA from E12.5 WT (white bars), E14.5 WT (dark gray bars),
E18.5 WT (light gray bars). Different E12.5 cDNA preparations were used in the top and bottom panels of B. All samples were done in triplicate and standardized to Hprt1. Fold
activation and standard deviations were calculated relative to E14.5 WT based on the ΔCt values of each sample compared to the ΔCt of Hprt1.
456 M.L. Brinkmeier et al. / Genomics 93 (2009) 449–460developing vertebrates (Rax) [37,60,63–71]. These genes correspond to
over ﬁfteen different homeodomain classes including the LIM, Paired
(Prd), Paired-like (Prd-like) and POU homeobox families [reviewed by
[72]]. Given the importance of known genes from these gene families
in pituitary organogenesis such as Prop1, Pou1f1, Pitx1, and Pitx2, the
identiﬁcation of Adnp (POU-like), Prrx2 (Prd), and Prrxl1 (Prd),
suggests that these genes may also play important roles in driving
cell proliferation and/or differentiation during the formation of the
pituitary gland. Mutations in some of these genes may underlie some
cases of MPHD, where the current genetic cause is unknown.
Interestingly, Meox2, Otx2, Emx2, and Zeb2 are differentially
expressed in the developing Rathke's pouch between E12.5 and
E18.5. No obvious differences in pituitary cell speciﬁcation are noted in
Emx2mutant mice [87]. Meox2 and Otx2 are elevated in the Prop1df/df
E14.5 pituitary relative to E14.5 wild type, and Prop1df/df newborns
have ectopic, elevated expression of Otx2 compared to wild type
littermates (Mortensen, unpublished observation). Meis1 and Adnp
are reduced in the Prop1df/df E14.5 pituitary relative to E14.5 WT. The
dynamic expression patterns of these homeobox genes in the
developing pituitary raise the question of whether they are regulated
by Prop1 and whether they have functional roles in pituitary
development.
Some of the remaining homeobox genes identiﬁed represent novel
classes of homeobox genes, not previously found in the developing
pituitary. For example, three zinc ﬁnger (ZF) homeobox genes were
identiﬁed in the encyclopedia (Table 4). Zeb2 expressionwas detected
at low levels at E12.5, expression levels increased at both E14.5 and
E18.5 in normal mice and expression was reduced in the Prop1df/dfE14.5 pituitary (Fig. 4), and Zhx1 has been detected at e12.5 by in situ
hybridization (data not shown). Mutations in one of these genes, ZEB2
or ZFHX1B, cause Mowat Wilson Syndrome, a human disorder char-
acterized by a distinctive facial phenotype in association with mental
retardation, microcephaly, and short stature [73]. Because this gene is
expressed in human pituitary, it is intriguing to hypothesize that
affected individuals with this syndrome have a pituitary defect [60].
Several genes belonging to the TALE family of homeobox genes
were identiﬁed in the embryonic pituitary (Pbx2,Meox2,Meis1,Meis2,
Pknox2, Tgif1, and Tgif2). Genes from this family are required to specify
cell fate in numerous organs including the spleen, and they may play a
similar role in the developing pituitary [74]. The TALE gene Pbx1
regulates expression of the Fshb gene in pituitary gonadotrope-like
cells and Gnrh1 in the hypothalamus [64,75]. MEIS2 interacts with
LHX2 to regulate Cga expression in pituitary gonadotrope-like cells
[66]. Our expression analysis of Meox2 suggests that Prop1 may
repress its expression during pituitary development.
One of the current challenges in the ﬁeld is to determine how the
various signaling pathways interact with each other during pituitary
organogenesis. BMP and FGF signals inﬂuence anterior pituitary cell
differentiation [1,55], and SHH signaling may participate in boundary
formation with FGF and BMP signaling in the ventral diencephalon
[54,55]. Cross talk between the WNT, BMP, FGF and SHH pathways is
evident in Tcf7l2, Wnt5a, and noggin mutants, which exhibit pituitary
developmental abnormalities [2,24,54]. Using the embryonic pituitary
encyclopedia we identiﬁed 79 additional BMP, FGF, NOTCH, SHH or
WNT pathway members with novel expression in the developing
pituitary. One such example is Fgf13, which is critical for neural
Table 5
Identiﬁcation of signaling-related genes in the embryonic pituitary encyclopediaa
Gene symbol Gene name
Fgf-relatedb
Fgf10 Fibroblast growth factor 10
Fgf13 Fibroblast growth factor 13
Fgf14 Fibroblast growth factor 14
Fgf17 Fibroblast growth factor 17
Fgfr1 Fibroblast growth factor receptor 1
Fgfr2 Fibroblast growth factor receptor 2
Fibp Fibroblast growth factor intracellular binding protein
Frs3 Fibroblast growth factor receptor substrate 3
Spry1 Sprouty homolog 1 (Drosophila)
Spry2 Sprouty homolog 2 (Drosophila)
Spred2 Sprouty-related, EVH1 domain containing 2
Sp3 Trans-acting transcription factor 3
Tbx3 T-box 3
BMP-relatedc
Id2 Inhibitor of DNA binding 2
Id3 Inhibitor of DNA binding 3
Tgfβi Transforming growth factor, beta induced
Functional cross talkd
Ascl1⁎ Achaete-scute complex homolog-like 1 (Drosophila)
Id1⁎ Inhibitor of DNA binding 1
Jun⁎ Jun oncogene
Neurod1⁎ Neurogenic differentiation 1
a A subset of the 63 genes identiﬁed is shown. The complete list is available in
Supplementary Figure 1.
b Of the Fgf genes detected, only Fgf10 was previously known to be expressed in the
pituitary gland.
c The expression patterns of these were studied by in situ hybridization.
d The asterisk⁎ indicates genes in the basic helix–loop–helix family.
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identiﬁed in the encyclopedia (Spry1, Spry2 and Spred2). Spry1, Spry2,
and Spry4 expressionwas previously reported in E14.5 Rathke's pouch
[77]. Sprouty genes have highly conserved roles as antagonists of FGF
signaling, which can affect differentiation [78,79]. Thus, several
members of the Sprouty family may regulate FGF signaling during
pituitary organogenesis.
An important application of our studies lies in the ability to utilize
the full-length cDNA clones. Some examples are the full-length cDNA
clones for the Fstl1, Id3, and Six6 genes that were used for expres-
sion analysis by in situ hybridization in pituitary development in
demonstrating the important role of noggin [54]. Full-length cDNA
clones for the forkhead transcription factor Foxl2 and numerous
members of both theWnt and Frizzled gene families, (Fzd6, Axin2 and
Dvl2, see Supplementary Table 1) have been invaluable [2,18].
In conclusion, the embryonic pituitary encyclopedia represents a
valuable gene discovery tool that can be used to identify novel genes
and pathways in the developing wild type and mutant pituitary
(Prop1df/df) and to initiate functional studies. We have just scratched
the surface and anticipate that this full-length cDNA encyclopedia will




Prop1df/+ mouse stocks were obtained from Dr. A. Bartke (South-
ern Illinois University, Carbondale, Ill.) in 1988 and maintained at the
University of Michigan according to NIH guidelines. Heterozygote
carriers were intercrossed to generate timed pregnancies and the
morning after mating was designated as E0.5. Developing pituitary
glands were dissected from E14.5 embryos with the aid of a dissecting
microscope and were individually stored in RNA Later (Ambion,
Austin, TX) at−20 °C. Genomic DNAwas extracted from the yolk sac,genotyping was performed as described [21], and pituitaries were
pooled for RNA extraction and cDNA generation following genotyping.
CD1 mice were purchased from Charles River Laboratories (Wilming-
ton, MA) as timed pregnancies and pituitary glands were dissected
from E12.5, E14.5, and E18.5 embryos. Pituitaries were pooled for RNA
extraction and cDNA generation. The University of Michigan Commit-
tee on Use and Care of Animals approved all experiments.
Library generation
Pituitary tissue for library generation was prepared as described
[38]. Brieﬂy, starting from 50 µg of total RNA, ﬁrst strand cDNA was
prepared with an anchored oligo-dT primer adapter [80] and the
cDNAwas cap-selected [81] and subsequently cloned in a Lambda FLC
I vector [41]. Libraries were excised into plasmids and sequenced.
E14.5 WT was given the library ID K7, E14.5 Prop1df/df was K8, and
E12.5 WT was K9 [38]. Additionally, subtracted libraries were pre-
pared from E14.5 WT minus E14.5 Prop1df/df and E14.5 WT minus
E12.5 WT, using established procedures [82].
Database generation
Mouse UniGene Build #159 (Mm.seq and Mm.seq.uniq) and
Mouse RefSeq Release 20 were obtained from NCBI FTP servers,
along with the ‘blastall’ program used to perform the BLAST
identiﬁcations. Each cDNA sequence was ﬁrst BLASTed against the
Mm.seq.uniq dataset, and then against the full mouse UniGene set
(Mm.seq). All cDNA sequences were also BLASTed against RefSeq to
provide an alternative identiﬁcation.
A database was constructed to contain the sequences themselves,
along with Riken identiﬁcation and a ‘library’ identiﬁcation, indicative
of the tissue source alongwith the UniGene and RefSeq identiﬁcations,
where obtainable. Web-based search functions were developed to
allow exploration of the contents of the various libraries by sequence,
gene name, etc. From the GO Consortium (www.geneontology.org)
we downloaded a database of GO identiﬁers in hierarchical format
(10/31/06 release). This data, along with ﬁles from the NCBI ‘Gene’
database (‘gene2go’, ‘gene2unigene’) allowed us to query our UniGene
identiﬁcations using GO terminology.
Gene Ontology (GO) terminology analysis
Over-represented Gene Ontology (GO) terms in the set of unique
sequences from each library as well as the intersecting sequences for
all libraries were detected using amodiﬁcation of the standard Fisher's
exact test [83]. Brieﬂy, we selected those sequences that were unique
to each library based on the UniGene ID and mapped these IDs to
Entrez Gene IDs using the mouseLLMappings package of Bioconductor
(http://www.bioconductor.org). We mapped the union of all
sequences in each library to Entrez Gene to use as the ‘universe’ from
which the unique sequences were selected. In other words, the usual
heuristic explanation of a Fisher's exact test is the idea of selecting
colored balls from an urn. In our case, the unique sequences from each
library are the balls thatwere selected fromtheurn, and theunion of all
sequences in each library is the ‘universe’ of balls in the urn. We
computed over-representation of GO terms using the topGOpackage of
Bioconductor, which uses the directed acyclic graph (DAG) structure of
the GO ontologies to decorrelate signiﬁcant subordinate terms from
considerationwhen estimating the signiﬁcance of higher-order terms.
In situ hybridization
RNA in situ hybridization was performed as described previously
[84]. Dlx1, Dlx3, Rax, Zhx1, Id2, Id3 and Tgfbi cDNAs were isolated from
the embryonic pituitary encyclopedia [38]. Id2, Id3 and Tgfbi were
linearized with NotI, and Dlx1, Dlx3, Rax and Zhx1 were linearized
Fig. 5. Developmental expression of 3 novel Bmp-related genes in the embryonic pituitary gland. (A) Expression of Id2 is predominantly in the intermediate lobe (IL) and around the
lumen of the pituitary and is excluded from the forming anterior lobe (delineated by the black dashed line). Expression is also detected in the ventral diencephalon (VD). This
expression pattern persists at E14.5 (B). (C) At E12.5 Id3 is expressed in the IL and dorsal part of the cells surrounding the pituitary lumen (indicated by the horizontal black line) and
this expression pattern continues at E14.5 (D). (E) At E12.5 Tgfbi was detected in the mesenchymal tissue immediately surrounding the developing pituitary (shown by the black
arrows). By E14.5 (F), Tgfbi expression becomes stronger in the mesenchyme and is also detected surrounding the posterior pituitary (PP) (shown by the black arrows).
458 M.L. Brinkmeier et al. / Genomics 93 (2009) 449–460with SacII. T3 polymerase was used in all cases to generate antisense
probes.
RT-PCR and PCR
RNAwas extracted from pituitary tissue dissected from CD1mouse
embryos at E12.5, E14.5, and E18.5 and stored in RNAlater (Ambion,
Foster City, CA) following the recommended commercial protocol.
RNA was further puriﬁed via RNAqueous 4PCR (Ambion, Foster City,
CA). cDNA was prepared from total RNA using the Superscript First
Strand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA). Brieﬂy,
5 μg total RNA was incubated at 42 °C for 50 min in a 10 μl reaction
containing 2 μl cDNA buffer, 4 μl MgCl2, 2 μl 0.1 μl DTT, and 1 μl of
Superscript II RT enzyme. Standard PCR reaction components at ﬁnalconcentrations were 1×PCR Reaction buffer (Roche, Indianapolis, IN),
1.5 mM MgCl2 (Perkin Elmer, Waltham, MA), 200 mM dNTP mix
(Roche), and 0.4 U GoTaq polymerase (Perkin Elmer) per 25 μl
reaction. Standard reactions contained 25–50 ng template cDNA.
All PCR reactions were performed using the following conditions:
94 °C; 4 min, followed by 30 cycles of 94 °C; 30 s, PCR-speciﬁc
annealing temperature; 30 s and 72 °C; 30 s, followed by 1 cycle of
72 °C; 10 min. PCR-speciﬁc annealing temperatures and primers are
listed in Supplementary Table 2.
Quantitative Real Time PCR was performed using TaqMan Gene
Expression Assays On Demand (Applied Biosystems, Foster City, CA).
Brieﬂy 25–50 ng of template cDNA was added to 10 μl Taqman
Universal PCR Master Mix (Applied Biosystems), 8 μl double distilled
H2O, and 1 μl TaqMan gene speciﬁc primer set. All samples were done
459M.L. Brinkmeier et al. / Genomics 93 (2009) 449–460in triplicate and standardized to Hprt1. Real Time PCR was performed
using the Prism 7000 Sequence Detection System (Applied Biosys-
tems). Fold activation and standard deviations were determined as
previously described [85].
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